Loading...

We've got a brand new version of Simply Wall St! Try it out

NHS Industries

CNSX:NHS
Snowflake Description

Worrying balance sheet with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
NHS
CNSX
CA$866K
Market Cap
  1. Home
  2. CA
  3. Real Estate
Company description

NHS Industries Ltd. engages in the development and rental of real estate properties and facilities in Canada. The last earnings update was 20 days ago. More info.


Add to Portfolio Compare Print
NHS Share Price and Events
7 Day Returns
-50%
CNSX:NHS
-0.8%
CA Real Estate
1.2%
CA Market
1 Year Returns
-64.3%
CNSX:NHS
5.2%
CA Real Estate
-0.2%
CA Market
NHS Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
NHS Industries (NHS) -50% 25% -28.6% -64.3% - -
CA Real Estate -0.8% 0.8% 1.1% 5.2% 40.5% 38.8%
CA Market 1.2% 4.2% 1.5% -0.2% 8.4% 1.8%
1 Year Return vs Industry and Market
  • NHS underperformed the Real Estate industry which returned 5.2% over the past year.
  • NHS underperformed the Market in Canada which returned -0.2% over the past year.
Price Volatility
Industry
5yr Volatility vs Market

NHS Value

 Is NHS Industries undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for NHS Industries. This is due to cash flow or dividend data being unavailable. The share price is CA$0.025.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for NHS Industries's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are NHS Industries's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
CNSX:NHS PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-06-30) in CAD CA$-0.03
CNSX:NHS Share Price ** CNSX (2019-09-13) in CAD CA$0.03
Canada Real Estate Industry PE Ratio Median Figure of 21 Publicly-Listed Real Estate Companies 12.69x
Canada Market PE Ratio Median Figure of 538 Publicly-Listed Companies 14.15x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of NHS Industries.

CNSX:NHS PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= CNSX:NHS Share Price ÷ EPS (both in CAD)

= 0.03 ÷ -0.03

-0.86x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • NHS Industries is loss making, we can't compare its value to the CA Real Estate industry average.
  • NHS Industries is loss making, we can't compare the value of its earnings to the Canada market.
Price based on expected Growth
Does NHS Industries's expected growth come at a high price?
Raw Data
CNSX:NHS PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -0.86x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
North America Real Estate Industry PEG Ratio Median Figure of 13 Publicly-Listed Real Estate Companies 0.39x
Canada Market PEG Ratio Median Figure of 246 Publicly-Listed Companies 0.98x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for NHS Industries, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on NHS Industries's assets?
Raw Data
CNSX:NHS PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-06-30) in CAD CA$0.02
CNSX:NHS Share Price * CNSX (2019-09-13) in CAD CA$0.03
Canada Real Estate Industry PB Ratio Median Figure of 40 Publicly-Listed Real Estate Companies 0.84x
Canada Market PB Ratio Median Figure of 2,452 Publicly-Listed Companies 1.44x
CNSX:NHS PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= CNSX:NHS Share Price ÷ Book Value per Share (both in CAD)

= 0.03 ÷ 0.02

1.18x

* Primary Listing of NHS Industries.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • NHS Industries is overvalued based on assets compared to the CA Real Estate industry average.
X
Value checks
We assess NHS Industries's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Real Estate industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Real Estate industry average (and greater than 0)? (1 check)
  5. NHS Industries has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

NHS Future Performance

 How is NHS Industries expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as NHS Industries has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
34.4%
Expected Real Estate industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is NHS Industries expected to grow at an attractive rate?
  • Unable to compare NHS Industries's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare NHS Industries's earnings growth to the Canada market average as no estimate data is available.
  • Unable to compare NHS Industries's revenue growth to the Canada market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
CNSX:NHS Future Growth Rates Data Sources
Data Point Source Value (per year)
Canada Real Estate Industry Earnings Growth Rate Market Cap Weighted Average 34.4%
Canada Real Estate Industry Revenue Growth Rate Market Cap Weighted Average 5.4%
Canada Market Earnings Growth Rate Market Cap Weighted Average 12.6%
Canada Market Revenue Growth Rate Market Cap Weighted Average 6%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
CNSX:NHS Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in CAD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
CNSX:NHS Past Financials Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income *
2019-06-30 0 0 -1
2019-03-31 0 0 -1
2018-12-31 0 0 -1
2018-09-30 0 0 0
2018-06-30 0 0 0
2018-03-31 0 0 0
2017-12-31 0 0 0
2017-09-30 0 0 0
2017-06-30 0 0 0
2017-03-31 0 0 0
2016-12-31 0 0 0

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if NHS Industries is high growth as no earnings estimate data is available.
  • Unable to determine if NHS Industries is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
CNSX:NHS Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from NHS Industries Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:NHS Past Financials Data
Date (Data in CAD Millions) EPS *
2019-06-30 -0.03
2019-03-31 -0.03
2018-12-31 -0.02
2018-09-30 0.00
2018-06-30 0.00
2018-03-31 0.00
2017-12-31 0.01
2017-09-30 -0.01
2017-06-30 -0.01
2017-03-31 -0.01
2016-12-31 -0.01

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if NHS Industries will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. NHS Industries's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Real Estate companies here
  2. NHS Industries's competitive advantages and company strategy can generally be found in its financial reports archived here.
  3. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess NHS Industries's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Canada market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Canada market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
NHS Industries has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

NHS Past Performance

  How has NHS Industries performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare NHS Industries's growth in the last year to its industry (Real Estate).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • NHS Industries does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare NHS Industries's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare NHS Industries's 1-year growth to the CA Real Estate industry average as it is not currently profitable.
Earnings and Revenue History
NHS Industries's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from NHS Industries Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:NHS Past Revenue, Cash Flow and Net Income Data
Date (Data in CAD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-06-30 0.10 -0.91 0.10
2019-03-31 0.10 -0.85 0.12
2018-12-31 0.10 -0.52 0.10
2018-09-30 0.10 0.03 0.11
2018-06-30 0.10 0.01 0.12
2018-03-31 0.10 0.07 0.07
2017-12-31 0.09 0.09 0.07
2017-09-30 0.09 -0.15 0.03
2017-06-30 0.09 -0.07 0.03
2017-03-31 0.08 -0.08 0.02
2016-12-31 0.08 -0.09 0.02
2015-12-31 0.08 -0.79 0.02

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if NHS Industries has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if NHS Industries has efficiently used its assets last year compared to the CA Real Estate industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if NHS Industries improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess NHS Industries's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Real Estate industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
NHS Industries has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

NHS Health

 How is NHS Industries's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up NHS Industries's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • NHS Industries is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • NHS Industries's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of NHS Industries's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is not covered by short term assets, assets are 0.8x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from NHS Industries Company Filings, last reported 2 months ago.

CNSX:NHS Past Debt and Equity Data
Date (Data in CAD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-06-30 0.74 0.63 0.04
2019-03-31 0.86 0.63 0.07
2018-12-31 1.00 1.30 0.75
2018-09-30 1.06 1.31 0.77
2018-06-30 1.14 1.31 0.78
2018-03-31 1.16 1.31 0.37
2017-12-31 1.20 1.32 0.31
2017-09-30 0.87 1.32 0.20
2017-06-30 -0.29 2.16 0.02
2017-03-31 -0.28 2.16 0.02
2016-12-31 -0.44 2.17 0.02
2015-12-31 -0.35 1.85 0.01
  • NHS Industries's level of debt (85.2%) compared to net worth is high (greater than 40%).
  • Unable to establish if NHS Industries's debt level has increased without past 5-year debt data.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • NHS Industries has less than a year of cash runway based on current free cash flow.
  • NHS Industries has less than a year of cash runway if free cash flow continues to grow at historical rates of 33.4% each year.
X
Financial health checks
We assess NHS Industries's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. NHS Industries has a total score of 1/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

NHS Dividends

 What is NHS Industries's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from NHS Industries dividends.
If you bought CA$2,000 of NHS Industries shares you are expected to receive CA$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate NHS Industries's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate NHS Industries's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
CNSX:NHS Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Canada Real Estate Industry Average Dividend Yield Market Cap Weighted Average of 15 Stocks 1.9%
Canada Market Average Dividend Yield Market Cap Weighted Average of 333 Stocks 3.5%
Canada Minimum Threshold Dividend Yield 10th Percentile 1.2%
Canada Bottom 25% Dividend Yield 25th Percentile 2%
Canada Top 25% Dividend Yield 75th Percentile 5.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as NHS Industries has not reported any payouts.
  • Unable to verify if NHS Industries's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of NHS Industries's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as NHS Industries has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess NHS Industries's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.2%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can NHS Industries afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. NHS Industries has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

NHS Management

 What is the CEO of NHS Industries's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Carman Parente
COMPENSATION CA$0
AGE 66
TENURE AS CEO 9.7 years
CEO Bio

Mr. Carman Parente has been Chief Executive Officer and Director of Nhs Industries Ltd. (“Company”) since January 01, 2010 and serves as its President since 2007. Mr. Parente has founded Natural Health Solutions, Inc. in 2005. In 2007, Mr. Parente founded NHS Industries Inc. He served as the President of New Age Farm Inc. since September 27, 2013 until June 29, 2018 and served as its Chief Executive Officer from September 27, 2013 to June 29, 2018. He serves as the Chief Executive Officer and President at Carbon Products Industries, Inc. Mr. Parente serves as Chief Executive Officer, President and Chief Financial Officer of Go Green Capital Corp and has been its Director since September 2013. Mr. Parente served as Chief Financial Officer of Five Nines Ventures Ltd. from September 10, 2013 to June 2014. Mr. Parente served as Chief Executive Officer and President of Five Nines Ventures Ltd. from November 9, 2010 to December 10, 2013. Mr. Parente served as the Chairman of Sanwire Corporation from May 1, 2013 to November 30, 2013 and also served as its Chief Executive Officer until May 1, 2013, President from May 16, 2011 to May 1, 2013 and Treasurer since May 16, 2011. He served as Chief Financial Officer and Secretary of Sanwire Corporation. Mr. Parente is also a partner in a five and half acre greenhouse facility in the Vancouver lower main land. He served Chief Executive Officer and President of Stem Cell Authority, Ltd (Formerly Five Nines Ltd) since March 5, 2001. For the past twelve years, he has been President of CM Parente Consulting. Prior to starting his family consulting firm, he spent 15 years in various management capacities within the Canadian banking system. He is a business and financial consultant and since 1993, he has been working with numerous Canadian and US private and public venture capital companies, in a variety of industries which include manufacturing, internet technology, precious mineral exploration and oil and gas drilling, specifically in thearea of financing. Mr. Parente owns and operates a nutrecuticle distribution company operating throughout Canada as well as being a managing partner in a functional food processing venture. He serves as a Director of CM Parente Consulting. He has been a Director of NT Mining Corp. since May 16, 2011. He was a Director at New Age Farm Inc. since September 27, 2013 until June 29, 2018. He serves as a Director of Carbon Products Industries, Inc. He served as a Director of Sanwire Corporation from May 1, 2013 to November 30, 2013 and Five Nines Ventures Ltd., from November 9, 2010 to June 2014. He served as a Director of Stem Cell Authority, Ltd (formerly, Five Nines Ltd) since March 5, 2001. From 1980 to 1999, Mr. Parente served as a director/officer of numerous Canadian and U.S. public companies, his most recent past directorship was in 1999 where he started and brought to the U.S. market Euro Industries Ltd that is trading under Destiny Media Techs Inc. Mr. Parente holds a Diploma of Technology in Operations Management from British Columbia Institute of Technology as well as his C.I.M. Designation, Canadian Institute of Management, Ottawa.

CEO Compensation
  • Insufficient data for Carman to compare compensation growth.
  • Insufficient data for Carman to establish whether their remuneration is reasonable compared to companies of similar size in Canada.
Management Team

Carman Parente

TITLE
CEO, President & Director
AGE
66
TENURE
9.7 yrs

Anthony Chan

TITLE
CFO & Director
AGE
54
TENURE
2.8 yrs

David Johnson

TITLE
AGE
49

Catherine Pike

TITLE
AGE
60
Board of Directors Tenure

Average tenure and age of the NHS Industries board of directors in years:

2.8
Average Tenure
57
Average Age
  • The average tenure for the NHS Industries board of directors is less than 3 years, this suggests a new board.
Board of Directors

Carman Parente

TITLE
CEO, President & Director
AGE
66
TENURE
9.7 yrs

Anthony Chan

TITLE
CFO & Director
AGE
54
TENURE
2.8 yrs

David Johnson

TITLE
AGE
49
TENURE
2.8 yrs

Catherine Pike

TITLE
AGE
60
TENURE
2.8 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (CA$) Value (CA$)
26. Mar 19 Buy Carman Parente Individual 13. Mar 19 13. Mar 19 5,200,000 CA$0.05 CA$259,998
X
Management checks
We assess NHS Industries's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. NHS Industries has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

NHS News

Simply Wall St News

What Kind Of Shareholder Appears On The NHS Industries Ltd.'s (CNSX:NHS) Shareholder Register?

As Nassim Nicholas Taleb said, 'Don’t tell me what you think, tell me what you have in your portfolio.' With a market capitalization of CA$1.7m, NHS Industries is a small cap stock, so it might not be well known by many institutional investors. … View our latest analysis for NHS Industries CNSX:NHS Ownership Summary, May 20th 2019 What Does The Lack Of Institutional Ownership Tell Us About NHS Industries? … Insider Ownership Of NHS Industries The definition of company insiders can be subjective, and does vary between jurisdictions.

Simply Wall St -

What Kind Of Shareholder Appears On The NHS Industries Ltd.'s (CNSX:NHS) Shareholder Register?

Large companies usually have institutions as shareholders, and we usually see insiders owning shares in smaller companies. … It has a market capitalization of CA$1.0m, which means it wouldn't have the attention of many institutional investors. … institutional investors have not yet purchased shares.

Simply Wall St -

Should You Be Concerned About NHS Industries Ltd.'s (CNSX:NHS) ROE?

With that in mind, this article will work through how we can use Return On Equity (ROE) to better understand a business. … Another way to think of that is that for every CA$1 worth of equity in the company, it was able to earn CA$0.030. … Return on Equity = Net Profit ÷ Shareholders' Equity

Simply Wall St -

Do Institutions Own NHS Industries Ltd (CNSX:NHS) Shares?

The big shareholder groups in NHS Industries Ltd (CNSX:NHS) have power over the company. … Generally speaking, as a company grows, institutions will increase their ownership. … Taking a look at the our data on the ownership groups (below), it's seems that.

Simply Wall St -

With An ROE Of 5.89%, Has NHS Industries Ltd's (CNSX:NHS) Management Done Well?

and want to start learning about core concepts of fundamental analysis on practical examples from today's market. … NHS Industries Ltd (CNSX:NHS) delivered an ROE of 5.89% over the past 12 months, which is relatively in-line with its industry average of 6.58% during the same period. … View our latest analysis for NHS Industries

Simply Wall St -

Why NHS Industries Ltd's (CNSX:NHS) Ownership Structure Is Important

Today, I will be analyzing NHS Industries Ltd’s (CNSX:NHS) recent ownership structure, an important but not-so-popular subject among individual investors. … The impact of a company's ownership structure affects both its short- and long-term performance. … The effect of an active institutional investor with a similar ownership as a passive pension-fund can be vastly different on a company's corporate governance and accountability to shareholders.

Simply Wall St -

What does NHS Industries Ltd's (CNSX:NHS) Balance Sheet Tell Us About Its Future?

While small-cap stocks, such as NHS Industries Ltd (CNSX:NHS) with its market cap of CA$2.58m, are popular for their explosive growth, investors should also be aware of their balance sheet to judge whether the company can survive a downturn. … since poor capital management may bring about bankruptcies,

Simply Wall St -

NHS Company Info

Description

NHS Industries Ltd. engages in the development and rental of real estate properties and facilities in Canada. The company operates Langley Site is a five and a half acre agricultural property with a 48,000 square foot greenhouse facility on site; and a residential property. NHS Industries Ltd. was incorporated in 2001 and is headquartered in North Vancouver, Canada.

Details
Name: NHS Industries Ltd.
NHS
Exchange: CNSX
Founded: 2001
CA$865,990
34,639,602
Website: http://nhsindustries.ca
Address: NHS Industries Ltd.
1641 Lonsdale Avenue,
Suite 106,
North Vancouver,
British Columbia, V7M 2J5,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
CNSX NHS Common Shares Canadian National Stock Exchange CA CAD 05. Apr 2018
OTCPK NNHH.F Common Shares Pink Sheets LLC US USD 05. Apr 2018
Number of employees
Current staff
Staff numbers
0
NHS Industries employees.
Industry
Real Estate Operating Companies
Real Estate
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/09/15 01:28
End of day share price update: 2019/09/13 00:00
Last earnings filing: 2019/08/26
Last earnings reported: 2019/06/30
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.